The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
In this session, a series of case studies will be presented to educate on the different ways hematologic malignancies can present, along with insightful approaches to treatment.
Learning Objectives:
Describe important clinical decisions in the up-front management of complex clinical scenarios in blood cancers
Explain how patient age, comorbidities, and genetic markers influence treatment decisions in hematologic malignancies
Discuss key pharmacologic considerations associated with cancer therapies and adjunct medications for blood cancers
Summarize key aspects of collaborative care between the advanced practitioner and pharmacist to improve patient outcomes in hematologic malignancies
Speaker(s):
Rebecca
L. Rezac,
Clinical Pharmacist Specialist,
UCHealth Blood Disorders and Cell Therapies Center
Glen
Peterson,
DNP, ACNP,
UCHealth Blood Disorders and Cell Therapies Center
Keri
Halsema,
NP,
Nurse Practitioner,
University of Colorado